Skip to main content

ADXN · Addex Therapeutics Ltd. · Financials

Track ADXN — free
$3.14 +0.04 (+1.29%)
Market Cap
$3.65M
Shares
1.27M
Volume · Oct 6 1454 Avg daily vol (3M) 184K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
172.86K -57.8%
FY2025 Revenue FY2017–FY2025
Net Income
-6.73M -195.4%
FY2025 Net Income FY2017–FY2025
Operating Margin
-1628.25% -956.3pp
FY2025 Operating Margin FY2017–FY2025
Diluted EPS
-0.06 -185.7%
FY2025 Diluted EPS FY2019–FY2025
Operating Cash Flow
-2.17M +59.6%
FY2025 Operating Cash Flow FY2017–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017
CHF 172.86K 410.04K 1.62M 1.44M 3.15M 3.88M 2.83M 6.7M 499.89K
CHF 671.65K 854.31K 1.19M 8.24M 12.84M 10.37M 12.45M 4.92M 2.63M
CHF 2.32M 2.31M 2.67M 3.74M 5.82M 5.75M 4.98M 3.21M 1.11M
CHF 8472 192.7K 11.75K 8814 347.61K 378.75K 333.84K 2938 15.25K
CHF -2.81M -2.76M -2.24M -10.54M -15.51M -12.24M -14.6M -1.42M -3.24M
CHF 15.55K 3547 321.15K 292.31K 63.01K 650.63K 213.32K 220.17K 45.35K
CHF -6.84M -4.91M -2.5M -10.8M -15.35M -12.86M -14.78M -1.64M -3.28M
CHF 0 0 0 0 0 0 0 0 —
CHF -6.73M 7.06M -10.56M -20.8M -15.35M -12.86M -14.78M -1.64M -3.28M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current lease liabilities 2026-06-30 CHF 54,472 6-K filed 2026-09-28
Noncurrent lease liabilities 2026-06-30 CHF 23,023 6-K filed 2026-09-28
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1574232 CUSIP 00654J206 Visit website Investor relations